{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:32:46Z","timestamp":1784734366948,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s40122-015-0038-6","type":"journal-article","created":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T12:06:59Z","timestamp":1441195619000},"page":"169-178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Palmitoylethanolamide in Fibromyalgia: Results from Prospective and Retrospective Observational Studies"],"prefix":"10.1007","volume":"4","author":[{"given":"Rosaria","family":"Del Giorno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Skaper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Paladini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Coaccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,3]]},"reference":[{"issue":"8","key":"38_CR1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","volume":"17","author":"LP Queiroz","year":"2013","unstructured":"Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013;17(8):356.","journal-title":"Curr Pain Headache Rep"},{"key":"38_CR2","volume-title":"Malattie reumatiche","author":"S Todesco","year":"2007","unstructured":"Todesco S, Gambari PF, Punzi L. Malattie reumatiche. IV ed. Milano: McGraw-Hill; 2007.","edition":"IV"},{"issue":"5","key":"38_CR3","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/art.39043","volume":"67","author":"J Kim","year":"2015","unstructured":"Kim J, Loggia ML, Cahalan CM, et al. The somatosensory link in fibromyalgia: functional connectivity of the primary somatosensory cortex is altered by sustained pain and is associated with clinical\/autonomic dysfunction. Arthritis Rheumatol Hoboken NJ. 2015;67(5):1395\u2013405.","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"5","key":"38_CR4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/s13075-014-0425-0","volume":"16","author":"V Napadow","year":"2014","unstructured":"Napadow V, Harris RE. What has functional connectivity and chemical neuroimaging in fibromyalgia taught us about the mechanisms and management of \u201ccentralized\u201d pain? Arthritis Res Ther. 2014;16(5):425.","journal-title":"Arthritis Res Ther"},{"key":"38_CR5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/bs.pmbts.2014.11.007","volume":"131","author":"EA Romero-Sandoval","year":"2015","unstructured":"Romero-Sandoval EA, Sweitzer S. Nonneuronal central mechanisms of pain: glia and immune response. Prog Mol Biol Transl Sci. 2015;131:325\u201358.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"2","key":"38_CR6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1573397111666150619094819","volume":"11","author":"R Staud","year":"2015","unstructured":"Staud R. Cytokine and immune system abnormalities in fibromyalgia and other central sensitivity syndromes. Curr Rheumatol Rev. 2015;11(2):109\u201315.","journal-title":"Curr Rheumatol Rev"},{"issue":"2","key":"38_CR7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160\u201372.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"38_CR8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3899\/jrheum.100594","volume":"38","author":"F Wolfe","year":"2011","unstructured":"Wolfe F, Clauw DJ, Fitzcharles M-A, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011;38(6):1113\u201322.","journal-title":"J Rheumatol"},{"issue":"4","key":"38_CR9","first-page":"217","volume":"170","author":"T Dombernowsky","year":"2008","unstructured":"Dombernowsky T, Dreyer L, Bartels EM, Danneskiold-Sams\u00f8e B. Muscular strength in patients with fibromyalgia. A literature review. Ugeskr Laeger. 2008;170(4):217\u201324.","journal-title":"Ugeskr Laeger."},{"key":"38_CR10","first-page":"6","volume":"75","author":"P Mease","year":"2005","unstructured":"Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl. 2005;75:6\u201321.","journal-title":"J Rheumatol Suppl"},{"issue":"15","key":"38_CR11","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","volume":"311","author":"DJ Clauw","year":"2014","unstructured":"Clauw DJ. Fibromyalgia: a clinical review. JAMA. 2014;311(15):1547\u201355.","journal-title":"JAMA"},{"issue":"3","key":"38_CR12","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00482-008-0672-6","volume":"22","author":"C Sommer","year":"2008","unstructured":"Sommer C, H\u00e4user W, Gerhold K, et al. Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain. Schmerz Berl Ger. 2008;22(3):267\u201382.","journal-title":"Schmerz Berl Ger"},{"key":"38_CR13","author":"ME Tavel","year":"2015","unstructured":"Tavel ME. Somatic symptom disorders without known physical causes: one disease with many names? Am J Med. 2015;. doi: 10.1016\/j.amjmed.2015.04.041 .","journal-title":"Am J Med"},{"issue":"3","key":"38_CR14","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1533-2500.2008.00188.x","volume":"8","author":"S Coaccioli","year":"2008","unstructured":"Coaccioli S, Varrassi G, Sabatini C, Marinangeli F, Giuliani M, Puxeddu A. Fibromyalgia: nosography and therapeutic perspectives. Pain Pract Off J World Inst Pain. 2008;8(3):190\u2013201.","journal-title":"Pain Pract Off J World Inst Pain."},{"issue":"1 Suppl 88","key":"38_CR15","first-page":"S109","volume":"33","author":"L Dell\u2019Osso","year":"2014","unstructured":"Dell\u2019Osso L, Arnold L, Baroni S, et al. The inflammatory hypothesis of mood spectrum broadened to fibromyalgia and chronic fatigue syndrome. Clin Exp Rheumatol. 2014;33(1 Suppl 88):S109\u201316.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"38_CR16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.imlet.2014.01.009","volume":"161","author":"I Rodriguez-Pint\u00f3","year":"2014","unstructured":"Rodriguez-Pint\u00f3 I, Agmon-Levin N, Howard A, Shoenfeld Y. Fibromyalgia and cytokines. Immunol Lett. 2014;161(2):200\u20133.","journal-title":"Immunol Lett"},{"issue":"2","key":"38_CR17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ncprheum0091","volume":"2","author":"R Staud","year":"2006","unstructured":"Staud R, Rodriguez ME. Mechanisms of disease: pain in fibromyalgia syndrome. Nat Clin Pract Rheumatol. 2006;2(2):90\u20138.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"5","key":"38_CR18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/bjaceaccp\/mkp026","volume":"9","author":"JD Dedhia","year":"2009","unstructured":"Dedhia JD, Bone ME. Pain and fibromyalgia. Contin Educ Anaesth Crit Care Pain. 2009;9(5):162\u20136 (1).","journal-title":"Contin Educ Anaesth Crit Care Pain."},{"issue":"10","key":"38_CR19","first-page":"1552","volume":"18","author":"DJ Hawley","year":"1991","unstructured":"Hawley DJ, Wolfe F. Pain, disability, and pain\/disability relationships in seven rheumatic disorders: a study of 1522 patients. J Rheumatol. 1991;18(10):1552\u20137.","journal-title":"J Rheumatol"},{"issue":"12","key":"38_CR20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/09638280400009030","volume":"27","author":"S Bergman","year":"2005","unstructured":"Bergman S. Psychosocial aspects of chronic widespread pain and fibromyalgia. Disabil Rehabil. 2005;27(12):675\u201383.","journal-title":"Disabil Rehabil"},{"issue":"4","key":"38_CR21","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1521-6942(03)00035-4","volume":"17","author":"DJ Clauw","year":"2003","unstructured":"Clauw DJ, Crofford LJ. Chronic widespread pain and fibromyalgia: what we know, and what we need to know. Best Pract Res Clin Rheumatol. 2003;17(4):685\u2013701.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"38_CR22","first-page":"CD007938","volume":"3","author":"RA Moore","year":"2011","unstructured":"Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2011;3:CD007938.","journal-title":"Cochrane Database Syst Rev"},{"key":"38_CR23","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1471-2474-11-150","volume":"11","author":"S Straube","year":"2010","unstructured":"Straube S, Derry S, Moore RA, Paine J, McQuay HJ. Pregabalin in fibromyalgia\u2013responder analysis from individual patient data. BMC Musculoskelet Disord. 2010;11:150.","journal-title":"BMC Musculoskelet Disord"},{"issue":"2","key":"38_CR24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/jama.2008.944","volume":"301","author":"W H\u00e4user","year":"2009","unstructured":"H\u00e4user W, Bernardy K, U\u00e7eyler N, Sommer C. Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA. 2009;301(2):198\u2013209.","journal-title":"JAMA"},{"issue":"Suppl 2","key":"38_CR25","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1111\/j.1526-4637.2006.00178.x","volume":"8","author":"LM Arnold","year":"2007","unstructured":"Arnold LM. Duloxetine and other antidepressants in the treatment of patients with fibromyalgia. Pain Med Malden Mass. 2007;8(Suppl 2):S63\u201374.","journal-title":"Pain Med Malden Mass"},{"issue":"3","key":"38_CR26","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.pain.2008.02.024","volume":"136","author":"IJ Russell","year":"2008","unstructured":"Russell IJ, Mease PJ, Smith TR, et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain. 2008;136(3):432\u201344.","journal-title":"Pain"},{"issue":"6","key":"38_CR27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jpain.2010.01.002","volume":"11","author":"W H\u00e4user","year":"2010","unstructured":"H\u00e4user W, Petzke F, Sommer C. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain Off J Am Pain Soc. 2010;11(6):505\u201321.","journal-title":"J Pain Off J Am Pain Soc"},{"issue":"20","key":"38_CR28","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1021\/ja01577a066","volume":"79","author":"FA Kuehl","year":"1957","unstructured":"Kuehl FA, Jacob TA, Ganley OH, Ormond RE, Meisinger MAP. The identification of N-(2-Hydroxyethyl)-Palmitamide as a naturally occurring anti-inflammatory agent. J Am Chem Soc. 1957;79(20):5577\u20138.","journal-title":"J Am Chem Soc"},{"key":"38_CR29","author":"SD Skaper","year":"2015","unstructured":"Skaper SD, Facci L, Barbierato M, Zusso M, Bruschetta G, Impellizzeri D, et al. N-Palmitoylethanolamine and neuroinflammation: a novel therapeutic strategy of resolution. Mol Neurobiol. 2015. doi: 10.1007\/s12035-015-9253-8 .","journal-title":"Mol Neurobiol"},{"issue":"2","key":"38_CR30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10787-013-0191-7","volume":"22","author":"SD Skaper","year":"2014","unstructured":"Skaper SD, Facci L, Fusco M, Della Valle MF, Zusso M, Costa B, et al. Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain. Inflammopharmacology. 2014;22(2):79\u201394.","journal-title":"Inflammopharmacology"},{"key":"38_CR31","doi-asserted-by":"crossref","unstructured":"Aloe L, Leon A, Levi-Montalcini R. A proposed autacoid mechanism controlling mastocyte behaviour. Agents Actions. 1993;39 Spec No:C145\u20137.","DOI":"10.1007\/BF01972748"},{"issue":"9","key":"38_CR32","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1526-4637.2012.01432.x","volume":"13","author":"A Gatti","year":"2012","unstructured":"Gatti A, Lazzari M, Gianfelice V, Di Paolo A, Sabato E, Sabato AF. Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis. Pain Med Malden Mass. 2012;13(9):1121\u201330.","journal-title":"Pain Med Malden Mass"},{"issue":"3","key":"38_CR33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/ejn.12440","volume":"39","author":"L Luongo","year":"2014","unstructured":"Luongo L, Maione S, Di Marzo V. Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions. Eur J Neurosci. 2014;39(3):401\u20138.","journal-title":"Eur J Neurosci"},{"issue":"6116","key":"38_CR34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1126\/science.1230720","volume":"339","author":"I Tabas","year":"2013","unstructured":"Tabas I, Glass CK. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science. 2013;339(6116):166\u201372.","journal-title":"Science"},{"issue":"6","key":"38_CR35","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.biochi.2010.01.006","volume":"92","author":"S Petrosino","year":"2010","unstructured":"Petrosino S, Iuvone T, Di Marzo V. N-Palmitoyl-ethanolamine: biochemistry and new therapeutic opportunities. Biochimie. 2010;92(6):724\u20137.","journal-title":"Biochimie"},{"key":"38_CR36","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12974-014-0136-0","volume":"11","author":"D Impellizzeri","year":"2014","unstructured":"Impellizzeri D, Bruschetta G, Cordaro M, et al. Micronized\/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain. J Neuroinflammation. 2014;11:136.","journal-title":"J Neuroinflammation"},{"key":"38_CR37","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fncel.2014.00238","volume":"8","author":"CM Freitag","year":"2014","unstructured":"Freitag CM, Miller RJ. Peroxisome proliferator-activated receptor agonists modulate neuropathic pain: a link to chemokines? Front Cell Neurosci. 2014;8:238.","journal-title":"Front Cell Neurosci"},{"key":"38_CR38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/978-3-540-79090-7_12","volume":"194","author":"RJ Miller","year":"2009","unstructured":"Miller RJ, Jung H, Bhangoo SK, White FA. Cytokine and chemokine regulation of sensory neuron function. Handb Exp Pharmacol. 2009;194:417\u201349.","journal-title":"Handb Exp Pharmacol"},{"issue":"2","key":"38_CR39","first-page":"99","volume":"26","author":"I Marini","year":"2012","unstructured":"Marini I, Bartolucci ML, Bortolotti F, Gatto MR, Bonetti GA. Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain. J Orofac Pain. 2012;26(2):99\u2013104.","journal-title":"J Orofac Pain"},{"issue":"8","key":"38_CR40","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2174\/187152711799219307","volume":"10","author":"A Truini","year":"2011","unstructured":"Truini A, Biasiotta A, Di Stefano G, et al. Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy-induced painful neuropathy. CNS Neurol Disord: Drug Targets. 2011;10(8):916\u201320.","journal-title":"CNS Neurol Disord: Drug Targets"},{"key":"38_CR41","first-page":"849623","volume":"2014","author":"C Schifilliti","year":"2014","unstructured":"Schifilliti C, Cucinotta L, Fedele V, Ingegnosi C, Luca S, Leotta C. Micronized palmitoylethanolamide reduces the symptoms of neuropathic pain in diabetic patients. Pain Res Treat. 2014;2014:849623.","journal-title":"Pain Res Treat"},{"key":"38_CR42","first-page":"35","volume":"25","author":"G Guida","year":"2010","unstructured":"Guida G, De Martino M, De Fabiani A, et al. La Palmitoiletanolamide (Normast\u00ae) en el dolor neurop\u00e1tico cr\u00f3nico por lumbociatalgia de tipo compresivo:estudio clinico mult\u00edc\u00e9ntrico. Dolor. 2010;25:35\u201342.","journal-title":"Dolor"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-015-0038-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T18:46:36Z","timestamp":1498243596000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40122-015-0038-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,3]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["38"],"URL":"https:\/\/doi.org\/10.1007\/s40122-015-0038-6","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,3]]}}}